Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis

Michael Praus, Désiré Collen, Robert D. Gerard

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Overexpression of plasminogen activator inhibitor 1 (PAI-1) reduces tumor cell migration in vitro and metastasis in mice in vivo by mechanisms involving either inhibition of urokinase plasminogen activator (u-PA) activity or competition for an integrin binding site on vitronectin. To analyze the effects of PAI-1 on tumor cell migration in vitro and metastasis in vivo, recombinant adenoviral vectors expressing wild-type or mutant PAI-1 proteins were constructed. The mutant PAI-1 proteins were defective in either vitronectin binding (PAI-1VN-), plasminogen activator inhibition (PAI-1INH-) or both (PAI-1VN-,INH-). In vitro, migration of HT1080 human fibrosarcoma cells through a reconstituted extracellular matrix (ECM) was reduced 73% by overexpression of wild-type PAI-1 and 65% by PAI-1VN- compared with control virus-infected cells. Migration of cells infected by virus expressing either PAI-1INH- or PAI-1VN-,INH- was unaffected, indicating a requirement for plasminogen activator inhibitory activity. In vivo, however, only overexpression of wild-type PAI-1 reduced the burden of metastasis by 68% compared with the control group. This indicates that both u-PA inhibition and PAI-1 ECM interactions contribute to the mechanism of PAI-1-mediated regulation of cell migration.

Original languageEnglish (US)
Pages (from-to)584-591
Number of pages8
JournalInternational Journal of Cancer
Volume102
Issue number6
DOIs
StatePublished - Dec 20 2002

Fingerprint

Vitronectin
Fibrosarcoma
Plasminogen Activators
Plasminogen Activator Inhibitor 1
Urokinase-Type Plasminogen Activator
Neoplasm Metastasis
Cell Movement
Replication Protein C
Extracellular Matrix
Viruses
Integrins
Neoplasms
Binding Sites
Control Groups

Keywords

  • Adenovirus
  • Cell movement
  • Gene transfer
  • Neoplasm metastasis
  • Plasminogen activator inhibitor 1
  • Vitronectin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis. / Praus, Michael; Collen, Désiré; Gerard, Robert D.

In: International Journal of Cancer, Vol. 102, No. 6, 20.12.2002, p. 584-591.

Research output: Contribution to journalArticle

@article{d14278e468c940cdae06467fbe343862,
title = "Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis",
abstract = "Overexpression of plasminogen activator inhibitor 1 (PAI-1) reduces tumor cell migration in vitro and metastasis in mice in vivo by mechanisms involving either inhibition of urokinase plasminogen activator (u-PA) activity or competition for an integrin binding site on vitronectin. To analyze the effects of PAI-1 on tumor cell migration in vitro and metastasis in vivo, recombinant adenoviral vectors expressing wild-type or mutant PAI-1 proteins were constructed. The mutant PAI-1 proteins were defective in either vitronectin binding (PAI-1VN-), plasminogen activator inhibition (PAI-1INH-) or both (PAI-1VN-,INH-). In vitro, migration of HT1080 human fibrosarcoma cells through a reconstituted extracellular matrix (ECM) was reduced 73{\%} by overexpression of wild-type PAI-1 and 65{\%} by PAI-1VN- compared with control virus-infected cells. Migration of cells infected by virus expressing either PAI-1INH- or PAI-1VN-,INH- was unaffected, indicating a requirement for plasminogen activator inhibitory activity. In vivo, however, only overexpression of wild-type PAI-1 reduced the burden of metastasis by 68{\%} compared with the control group. This indicates that both u-PA inhibition and PAI-1 ECM interactions contribute to the mechanism of PAI-1-mediated regulation of cell migration.",
keywords = "Adenovirus, Cell movement, Gene transfer, Neoplasm metastasis, Plasminogen activator inhibitor 1, Vitronectin",
author = "Michael Praus and D{\'e}sir{\'e} Collen and Gerard, {Robert D.}",
year = "2002",
month = "12",
day = "20",
doi = "10.1002/ijc.10767",
language = "English (US)",
volume = "102",
pages = "584--591",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis

AU - Praus, Michael

AU - Collen, Désiré

AU - Gerard, Robert D.

PY - 2002/12/20

Y1 - 2002/12/20

N2 - Overexpression of plasminogen activator inhibitor 1 (PAI-1) reduces tumor cell migration in vitro and metastasis in mice in vivo by mechanisms involving either inhibition of urokinase plasminogen activator (u-PA) activity or competition for an integrin binding site on vitronectin. To analyze the effects of PAI-1 on tumor cell migration in vitro and metastasis in vivo, recombinant adenoviral vectors expressing wild-type or mutant PAI-1 proteins were constructed. The mutant PAI-1 proteins were defective in either vitronectin binding (PAI-1VN-), plasminogen activator inhibition (PAI-1INH-) or both (PAI-1VN-,INH-). In vitro, migration of HT1080 human fibrosarcoma cells through a reconstituted extracellular matrix (ECM) was reduced 73% by overexpression of wild-type PAI-1 and 65% by PAI-1VN- compared with control virus-infected cells. Migration of cells infected by virus expressing either PAI-1INH- or PAI-1VN-,INH- was unaffected, indicating a requirement for plasminogen activator inhibitory activity. In vivo, however, only overexpression of wild-type PAI-1 reduced the burden of metastasis by 68% compared with the control group. This indicates that both u-PA inhibition and PAI-1 ECM interactions contribute to the mechanism of PAI-1-mediated regulation of cell migration.

AB - Overexpression of plasminogen activator inhibitor 1 (PAI-1) reduces tumor cell migration in vitro and metastasis in mice in vivo by mechanisms involving either inhibition of urokinase plasminogen activator (u-PA) activity or competition for an integrin binding site on vitronectin. To analyze the effects of PAI-1 on tumor cell migration in vitro and metastasis in vivo, recombinant adenoviral vectors expressing wild-type or mutant PAI-1 proteins were constructed. The mutant PAI-1 proteins were defective in either vitronectin binding (PAI-1VN-), plasminogen activator inhibition (PAI-1INH-) or both (PAI-1VN-,INH-). In vitro, migration of HT1080 human fibrosarcoma cells through a reconstituted extracellular matrix (ECM) was reduced 73% by overexpression of wild-type PAI-1 and 65% by PAI-1VN- compared with control virus-infected cells. Migration of cells infected by virus expressing either PAI-1INH- or PAI-1VN-,INH- was unaffected, indicating a requirement for plasminogen activator inhibitory activity. In vivo, however, only overexpression of wild-type PAI-1 reduced the burden of metastasis by 68% compared with the control group. This indicates that both u-PA inhibition and PAI-1 ECM interactions contribute to the mechanism of PAI-1-mediated regulation of cell migration.

KW - Adenovirus

KW - Cell movement

KW - Gene transfer

KW - Neoplasm metastasis

KW - Plasminogen activator inhibitor 1

KW - Vitronectin

UR - http://www.scopus.com/inward/record.url?scp=0037146737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037146737&partnerID=8YFLogxK

U2 - 10.1002/ijc.10767

DO - 10.1002/ijc.10767

M3 - Article

C2 - 12447999

AN - SCOPUS:0037146737

VL - 102

SP - 584

EP - 591

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -